Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...

Lenny Santoro was diagnosed with prostate cancer in 2011. Thanks to clinical trials Santoro participated in at the Duke ...

Ending clinical trials with no warning can put patients at risk.

Biotech and biopharma companies have battled with a drought of private investment in recent years but could now face ...

Transparent, well-designed clinical trials are a must. FastWave Medical's Scott Nelson has advice on how to get there.

Preliminary efficacy data from Phase 1/2 dose expansion cohort show durable responses and tumor shrinkage in a PD-(L)1 resistant “hot” tumor ...

Researchers analyzed pivotal and confirmatory trial characteristics, outcomes, and safety data for 102 cancer drug ...

Inclusion of female and Hispanic/Latino patients has increased over time, but most trials of metabolic dysfunction-associated ...

The FDA has approved GSK’s gepotidacin, the first antibiotic for uncomplicated urinary tract infections in 30 years. The drug has been approved for female adults and adolescents with UTIs caused by ...

Recent research is showing medical treatment for pregnant women often relies on clinical data from non-pregnant female ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...